Question 1 – Do I Qualify for Weight Loss Surgery?

In this 10 part series, New Jersey bariatric surgeon Dr. Alexander Abkin discusses 10 questions commonly asked by patients who are considering weight loss surgery.

Question 1 – Do I Qualify for Weight Loss Surgery?

 

Dr. Abkin Voted “Top Doc” in Bariatric Surgery by NJ Monthly Magazine for 17th Consecutive Year

Dr. Alexander Abkin, renowned bariatric surgeon and director of bariatric surgery at Saint Clare’s Health System (Dover) and HMH JFK University Medical Center (Edison), has once again been recognized by his peers as a “Top Doc” in the field of bariatric surgery by New Jersey Monthly Magazine. This prestigious award marks the 17th consecutive year that Dr. Abkin has been acknowledged for his exceptional contributions to the field of bariatric surgery in New Jersey. Read more

How Remote Work Might Add 800 Calories to Your Day and Why Weight Loss Surgery Can Help

The advent of remote work has revolutionized the way we conduct business, offering flexibility and convenience like never before. However, this shift to working from home has also brought about some unexpected challenges, one of which is the potential for significant weight gain. Surprisingly, many remote workers find themselves consuming an additional 800 calories and 3,500 fewer steps per day on average compared to their office counterparts, according to a new survey from the diet tracking app MyFitnessPal.

In this article, we’ll explore why this phenomenon occurs and how weight loss surgery can provide a solution for those struggling with weight gain during their remote work journey.

The Work-from-Home Culinary Trap

  • The Kitchen Proximity
    Working from home means your office is just steps away from the kitchen. This accessibility to food throughout the day can lead to more frequent snacking and, consequently, a higher calorie intake. In an office environment, you’re less likely to snack mindlessly because you have to make a conscious effort to visit the break room or vending machine.
  • Lack of Routine
    The structured routine of office life often dictates when you eat. With remote work, this routine can become disrupted. You may find yourself skipping breakfast, having irregular meal times, or grazing on snacks all day long. This erratic eating pattern can lead to overconsumption of calories.
  • Stress and Emotional Eating
    Remote work can be stressful, with blurred lines between professional and personal life. Stress and isolation can trigger emotional eating, as many people turn to food for comfort. This emotional connection to food can result in the consumption of extra calories.
  • Sedentary Lifestyle
    Remote work often involves prolonged periods of sitting in front of a computer screen. This sedentary lifestyle can lead to a decrease in physical activity, which can, in turn, contribute to weight gain.

Weight Loss Surgery: A Viable Solution

For individuals who have found themselves battling weight gain while working from home, weight loss surgery may be a beneficial solution. Here’s why:

  • Permanent Weight Loss
    Weight loss surgeries, such as gastric bypass or sleeve gastrectomy, can provide long-term weight loss results. These procedures help reduce the size of the stomach or alter the digestive process, leading to reduced food intake and better control over calorie consumption.
  • Improved Health
    Excessive weight gain can lead to a range of health issues, including diabetes, heart disease, and joint problems. Weight loss surgery can help improve or resolve these conditions, enhancing overall health and well-being.
  • Enhanced Quality of Life
    Maintaining a healthy weight can boost self-esteem and confidence, which can have a positive impact on both personal and professional life. Weight loss surgery can help individuals regain their self-confidence and lead a more active, fulfilling life.
  • Sustainable Lifestyle Changes
    Weight loss surgery is not a quick fix but a tool that facilitates sustainable lifestyle changes. Patients are required to make significant modifications to their diet and exercise habits post-surgery, helping them establish healthier routines that can counteract the remote work calorie trap.

Conclusion

While remote work offers undeniable benefits, it also presents unique challenges when it comes to weight management. The convenience and flexibility of working from home can lead to the consumption of an extra 800 calories per day, contributing to unwanted weight gain. For those struggling to control their weight, weight loss surgery can be a valuable solution, offering the potential for permanent weight loss, improved health, and an enhanced quality of life. However, it’s essential to consult with a healthcare professional to determine whether weight loss surgery is the right option for your specific circumstances. In the end, finding a balance between remote work and a healthy lifestyle is key to maintaining overall well-being.

Bariatric Procedure Outperforms Semaglutide in Patients With Obesity, Fatty Liver

A recent study was published comparing two treatments for people with obesity and a liver condition called metabolic dysfunction-associated steatotic liver disease (MASLD). The two treatments tested were bariatric surgery and a medication called semaglutide.

The findings showed that bariatric surgery led to more weight loss and better improvements in liver health compared to semaglutide. Many obese individuals also have MASLD, and losing weight is the main recommendation for treating it. Both bariatric surgery and semaglutide help people lose weight, but the study aimed to determine which one is more effective for improving liver health.

Dr. Reem Z. Sharaiha, the lead researcher, believes that using a combination of treatments may be the best approach for these patients. Semaglutide and similar medications are a good starting point, but some patients may plateau in their weight loss or want to stop taking the medication. That’s where bariatric surgery and similar procedures come in. On the other hand, patients treated with bariatric surgery may need help maintaining their weight loss, so medication could be beneficial for them.

In conclusion, the study suggests that a combination of treatments may be the future for managing obesity and MASLD, and the most important thing is to start treatment, regardless of the specific method used.

Please note, while our practice does not offer endoscopic sleeve gastroplasty (ESG), we do offer Vertical Sleeve Gastrectomy (VSG) and Roux-en-y Gastric Bypass (RNYGBP) procedures for qualified candidates who meet the criteria. 

Click here to read the full study. Call 973-410-9700 or contact us online to learn more.

JFK Spotlight: Bariatrics with Dr. Abkin

Joel Katz talks to Dr. Alexander Abkin about Bariatrics at Hackensack University JFK Medical Center. Click the link below to listen. Read more

FDA Adds Intestinal Blockage as Potential Side Effect to Ozempic, Wegovy

The U.S. Food and Drug Administration (FDA) has recently made a significant update to the label of Ozempic, a medication commonly prescribed for type 2 diabetes and increasingly used for weight loss. This update highlights a potential side effect that patients and healthcare providers should be aware of – intestinal blockage.  Another weight loss drug known as Wegovy, produced by the same manufacturer, also carries a warning about the possibility of ileus. Read more

Bariatric Surgery Linked to Reduced Risk of Obesity-Associated Cancers, New Study Finds

A groundbreaking study conducted over a decade has revealed compelling evidence that bariatric surgery could significantly lower the risk of obesity-associated cancers. The research, which followed patients for ten years, sheds light on the potential protective effects of this weight loss surgery against certain types of cancer. Let’s delve into the findings and explore the implications they hold for individuals struggling with obesity and its associated health risks.

Bariatric Surgery: A Potential Shield Against Obesity-Associated Cancers

The study, conducted over a span of ten years, compared the incidence of obesity-associated cancers in two groups: those who underwent bariatric surgery for weight loss and those who did not. The results were astonishing. Among the cohort that underwent weight loss surgery, only 2,206 patients developed obesity-associated cancers, in stark contrast to the 4,960 cases observed among those who did not opt for surgical intervention. This translates to a striking difference in the cumulative incidence of such cancers at the ten-year mark: 4% for the bariatric surgery group compared to 8.9% for the non-surgery group.

Understanding the Factors at Play

The study’s lead researcher, Dr. Chittajallu, acknowledged that while the underlying reasons for this protective effect against cancer remain unclear, bariatric surgery is known to mitigate inflammation, regulate insulin levels, and moderate hormone production. These mechanisms, in turn, contribute to a reduction in cancer risk. However, he emphasized that a more comprehensive understanding of how these factors interplay will necessitate further investigation and research.

The Role of Inflammation

The study’s findings resonate with the long-established link between obesity and a heightened risk of various types of cancer. Dr. Reem Z. Sharaiha, an associate professor of medicine at Weill Cornell Medical Center, highlighted the connection between obesity, inflammation, and cancer risk. Obese individuals often exhibit elevated levels of inflammatory markers, which contribute to their increased susceptibility to cancer. Weight loss, achieved through bariatric surgery, can lead to a decrease in these inflammatory markers and subsequently lower the risk of obesity-associated cancers.

Cautious Interpretation of Observational Studies

While the study’s outcomes are promising, it’s essential to approach them with caution. Dr. Loren Laine, the chair of the DDW Council and a professor of medicine at Yale School of Medicine, acknowledged the significance of the findings but cautioned against drawing hasty conclusions from retrospective observational studies. These types of studies can sometimes be influenced by unaccounted variables, necessitating a balanced perspective on the results.

Conclusion

The ten-year study on the effects of bariatric surgery in reducing the risk of obesity-associated cancers marks a significant step forward in understanding the intricate relationship between weight loss and cancer prevention. The remarkable reduction in cancer incidence among patients who underwent bariatric surgery underscores the potential health benefits of sustained weight loss. As researchers continue to explore the underlying mechanisms, these findings offer hope to individuals seeking effective strategies to mitigate the health risks associated with obesity.

Understanding Semaglutide and its Link to Gastroparesis

Obesity has become a global health crisis, with millions of people struggling to achieve sustainable weight loss and improve their overall health. Semaglutide, a medication commonly used for type 2 diabetes management, has been praised for its potential in aiding weight loss. However, recent research has shed light on its association with gastroparesis, a condition that affects the stomach’s ability to empty properly. As we delve into the link between semaglutide and gastroparesis, it becomes evident that bariatric surgery may be a more effective and safer option for those seeking sustained weight loss with minimal complications.

Understanding Semaglutide and its Link to Gastroparesis

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that mimics the functions of incretin hormones, leading to reduced appetite, delayed stomach emptying, and increased insulin secretion. In clinical trials, semaglutide has shown promising results in weight reduction, making it a potential game-changer in the field of obesity management.

However, the delayed gastric emptying caused by semaglutide can also lead to gastroparesis, a condition characterized by symptoms such as nausea, vomiting, bloating, and early satiety. The mechanism behind this adverse effect is not yet fully understood, and further research is needed to determine the risk factors and long-term consequences of gastroparesis related to semaglutide use.

Bariatric Surgery: A Better Option for Sustained Weight Loss

  • Mechanism of Action:
    Bariatric surgery encompasses various procedures that alter the gastrointestinal tract’s anatomy and physiology, leading to weight loss and improvement in metabolic conditions. Unlike semaglutide, which focuses on appetite suppression and delayed gastric emptying, bariatric surgery addresses the root cause of obesity by reducing stomach capacity and altering gut hormones.
  • Substantial Weight Loss:
    Numerous studies have shown that bariatric surgery results in significant and sustained weight loss. Procedures such as gastric bypass, sleeve gastrectomy, and gastric banding have been proven to be more effective than non-surgical approaches for long-term weight management.
  • Resolution of Co-morbidities:
    Obesity is often associated with various comorbidities like type 2 diabetes, hypertension, and sleep apnea. Bariatric surgery not only aids in weight loss but can also lead to the resolution or improvement of these metabolic conditions, enhancing overall health and quality of life.
  • Improvement in Metabolic Hormones:
    Bariatric surgery induces changes in gut hormones, including GLP-1, which play a vital role in appetite regulation and glucose metabolism. This hormonal shift contributes to the reduction of hunger, increased satiety, and better blood sugar control.
  • Long-term Efficacy:
    While semaglutide has demonstrated efficacy in clinical trials, the long-term safety and weight maintenance of this drug are yet to be fully understood. Bariatric surgery, on the other hand, has a well-documented long-term success rate in weight management, making it a reliable option for those seeking sustained weight loss.
  • Overall Health Benefits:
    Bariatric surgery not only results in weight loss but also improves cardiovascular health, reduces the risk of certain cancers, and enhances fertility in women with polycystic ovary syndrome (PCOS). These added health benefits make it a comprehensive solution for patients with severe obesity.

Conclusion

Semaglutide has shown promise in aiding weight loss, but its link to gastroparesis raises concerns about its long-term safety and efficacy. As we navigate the complexities of obesity management, it becomes evident that bariatric surgery offers a more comprehensive and effective solution for sustained weight loss with minimal complications. Nonetheless, each individual’s case is unique, and medical professionals must carefully evaluate the risks and benefits of both approaches before recommending the most suitable course of action. Research in this field is ongoing, and future advancements may lead to safer and more effective treatments for obesity and its related complications.

Call 973-410-9700 or contact us online to  learn more.

Ozempic Burp: What is it?

This article discusses the side effects of popular weight loss medications such as Ozempic, Wegovy, and Mounjaro. Read more